Field-Based Healthcare Account Executive - Cancer Screening

Guardant Health; United States; Sur place; USD 90 000 - 140 000; Plein temps

Résumé du poste

Guardant Health, a leader in precision oncology, is seeking a field-based Account Executive to promote the Shield colorectal cancer blood test to primary care providers. You will drive awareness, build strong provider relationships, and accelerate adoption of screening technologies that can impact patient outcomes.

You will collaborate with sales leadership to shape go-to-market strategies, meet sales targets, and ensure seamless integration of Shield into clinical workflows across your

Responsabilités

• Sales & Customer Engagement: Achieve sales targets through prospecting, relationships and national sales strategies.
• Target and Engage Healthcare Providers: Build relationships with providers to gain commitment to Shield CRC tests.
• Challenger Selling: Understand provider needs and show how Guardant's offerings improve outcomes and workflow.
• Educate and Support Providers: Train primary care practices on Shield to gain stakeholder support.
• Collaboration & Strategy: Work with clinical, marketing and product teams to align sales plans.
• Strategic Business Expansion: Identify new opportunities and partner with labs to expand reach.
• Plan & Execute Launches: Develop and execute launches for new cancer screening technologies.
• Market Insights & Analysis: Monitor trends and report insights to leadership.
• Customer Service & Operations: Maintain high-touch service and ensure regulatory compliance.

Description du poste

Guardant Health, a leader in precision oncology, is seeking a field-based Account Executive to promote the Shield colorectal cancer blood test to primary care providers. You will drive awareness, build strong provider relationships, and accelerate adoption of screening technologies that can impact patient outcomes.

You will collaborate with sales leadership to shape go-to-market strategies, meet sales targets, and ensure seamless integration of Shield into clinical workflows across your